Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.2804
-0.0296 (-9.55%)
At close: Sep 23, 2025
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of $777.74 million as of October 7, 2025. Its market cap has increased by 364.61% in one year.
Market Cap
777.74M
Enterprise Value
815.26M
Revenue
256.39M
Ranking
n/a
PE Ratio
32.34
Stock Price
$0.28
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 844.70M to 777.74M, a decrease of -7.93%. That is a compound annual growth rate of -1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 777.74M | 232.42% |
| Dec 31, 2024 | 233.96M | -18.73% |
| Dec 29, 2023 | 287.88M | -33.04% |
| Dec 30, 2022 | 429.89M | -62.94% |
| Dec 31, 2021 | 1.16B | -48.59% |
| Dec 31, 2020 | 2.26B | 146.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |